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Abstract
Abnormal hypertrophic arachnoid membranes are often observed in the brain–meningioma 
interface during microsurgery. They contain fibrosis and tumor cell clusters; however, preserva-
tion of the membranes does not always cause recurrence from the brain surface, and the optimal 
treatments in the interface remain unclear. We investigated the incidence of recurrence on the 
brain surface following extra-arachnoid dissection with an approach emphasizing preservation 
of the arachnoid membranes in meningiomas of World Health Organization (WHO) Grade I. 
The features of dissection cleavages in the interface were prospectively recorded at surgery. The 
patients were followed up with MR imaging regularly. In total, 111 patients were included. 
The median follow-up time was 97.0 (interquartile range [IQR] 70.0–124.0) months. The  cleavages 
in the interface were classified into three subgroups: the Extra-H group (n = 56) with extra- 
arachnoid resection and preservation of hypertrophic arachnoid membranes, the Extra-N group 
(n = 39) with extra-arachnoid resection having normal membranes, and the Subpial  resection 
group (n = 16). Tumors recurred in 13 (11.7%) patients at both the brain and dura mater (n = 1) or 
at the dura mater alone (n = 12). The median recurrence-free survival (RFS) of all recurrences 
was significantly related to the Simpson grades (P <0.01). For brain surface recurrence, the 
median RFS was not related to the subgroups. The Karnofsky Performance Scores (KPSs) signifi-
cantly improved in the patients except for the Subpial group at 3 months after surgery. This study 
revealed that hypertrophic arachnoid membranes preserved on the brain surface rarely caused 
recurrence from the brain in WHO Grade I meningiomas after a long-term follow-up.
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Introduction
Neurosurgeons have employed management  strategies 
aimed at maximizing tumor control while minimizing 
neurological morbidity, especially for benign menin-
giomas.1–4) Even after complete resection of convexity 
meningiomas, previous studies have reported consis-
tent recurrence rates of 1.8–11.1% either from the 
brain or dural attachment.5–7) Regarding surgical 
factors related to recurrence and progression, 
 discussions have been mainly focused on resection 
of the dura mater and bone.6–8,9,10) Recurrence from 
the brain surface may relate to two factors, brain 
invasion of meningioma and tumor remnant in the 
arachnoid membranes over the brain surface. Only 
a few studies have explored the surgical techniques 
used at the interface.11–14) Indeed, the clinical impli-
cations and optimal management of abnormal 
arachnoid membranes in the interface for preventing 
tumor recurrence and improving the patient neuro-
logical function remain unclear.
We previously reported that the connective tissue 
proliferation involves a spectrum of histological 
changes including hypertrophic arachnoid membranes 
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and the so-called capsule composed of tumor stroma, 
arachnoid mater, and arachnoid trabecules.15) The 
tumor cells were not highly proliferative in these 
arachnoid membranes with fibrotic changes.  Therefore, 
we hypothesized that we could minimize surgical 
morbidity protecting the brain surface with arach-
noid membranes in the interface while maximizing 
meningioma removal on the dural attachment. We 
prospectively recorded the features of the cleavage 
between the brain and the tumor during microsur-
gery for meningiomas, and followed the patients 
with immediate postoperative and regular magnetic 
resonance (MR) imaging. This study was conducted 
to investigate the incidence of tumor recurrence 
especially on the brain surface with extra-arachnoid 
and extrapial dissection preserving those hypertro-
phic arachnoid membranes, with a review of the 
long-term outcomes of patients with World Health 
Organization (WHO) Grade 1 meningiomas based 
on our 15 years of experience.
Materials and Methods
Patient population
After receiving approval from the institutional 
review board at Shizuoka Cancer Center (number 
28-J168-28-1-3), we performed an observational 
study of patients with meningiomas treated at 
Shizuoka Cancer Center between 2003 and 2020. 
The study analyzed a consecutive series of 147 patients 
with intracranial meningiomas surgically treated 
with an approach emphasizing preservation of the 
arachnoid membranes on the brain by the senior 
neurosurgeon (YN) in the institute and followed for 
a minimum of 4 years. The patients underwent 
craniotomy for resection of a WHO Grade I menin-
gioma as their initial therapy. We excluded patients 
with prior craniotomies for any reason, history of 
any other intracranial tumor, neurofibromatosis, or 
ventricular meningioma.
Microsurgical technique and perioperative 
management
The senior neurosurgeon prospectively employed 
a surgical strategy for meningiomas aimed at maxi-
mizing tumor control while minimizing the neuro-
logical deficits induced by surgery. Surgery was 
performed under general anesthesia with endotracheal 
intubation. Following small or medium standard 
craniotomy, resection was performed using classical 
microsurgical dissection techniques. Intratumoral 
volume reduction was performed, followed by 
dissection at the interface of the brain and tumor. 
Blunt or sharp dissection was conducted with special 
attention paid to the presence of the pial vascular 
supply, perforation of the pia mater, or hypertrophic 
arachnoid membrane.14) Efforts were taken to preserve 
the arachnoid membranes over critical structures, 
even if this resulted in leaving small tumor remnants 
adhered to the structures. If the so-called tumor 
capsule of connective tissue proliferation over the 
brain was detected, we dissected it while leaving 
a layer and subarachnoid vessels over the brain 
surface. We performed subpial removal of the tumor 
in patients with firm adhesion to the brain surface 
through the perforated pia mater in non-eloquent 
areas, and the exposed brain surface was covered 
with oxidized cellulose and artificial cerebrospinal 
fluid.
Patients routinely underwent postoperative MR 
imaging with contrast within 48 h after surgery to 
confirm the extent of removal, and they underwent 
follow-up neurological examinations and MR imaging 
3 and 6 months after surgery and annually thereafter.
Data collection and classification of treatments 
in cleavage
The features and dissection cleavages of the 
brain–meningioma interface were prospectively 
recorded by the consensus of the surgeons at 
surgery: condition of arachnoidal border (including 
critical tissue and vessels), dissection plane in the 
interface, preservation of the arachnoid membrane 
and pia mater, and extent of tumor resection in 
total and focused on dural attachment according 
to the Simpson grading system.8) The dissection 
plane and hypertrophic arachnoid membranes in 
the brain–tumor interface were classified into three 
subgroups: the Extra-H group, corresponding to 
extra-arachnoid and extrapial resection preserving 
layers of thick arachnoid membranes or capsule; 
the Extra-N group, corresponding to extra-arachnoid 
resection for cases with normal arachnoid membranes; 
and the Subpial group, corresponding to subpial 
total resection leaving no abnormal arachnoid 
membranes or capsule in the brain–tumor interface 
(Fig. 1, Supplementary Table 1. All Supplementary 
Tables are available Online.). Even a meningioma 
had a small pial defect in the interface, extra- 
arachnoid resection was achieved leaving thick or 
normal arachnoid membranes in Extra-H and 
Extra-N groups.
In this study, data collected included the patient 
age at surgery, sex, preoperative and postoperative 
functional status, tumor size, surrounding brain 
edema, radiological recurrence date, and WHO 
grades (classification in 2016).16) The tumor size 
was measured by the maximum diameter on contrast- 
enhanced MR images. The extent of removal was 
confirmed by MR imaging within 48 hours after 
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surgery in each case. Neurological morbidity was 
defined as aggravation of preoperative neurological 
deficits or new deficits that persisted beyond the 
first 30 days after surgery. The performance status 
was assessed immediately before surgery and 3 months 
postoperatively using the Karnofsky Performance 
Score (KPS). Any death within 30 days postopera-
tively was considered an operative death.
The preoperative evaluation of all patients included 
T1- and T2-weighted MR imaging with and without 
contrast media. Preoperative embolization was performed 
for larger tumors. Recurrence or progression was 
defined as documented significant growth of the tumor 
on follow-up MR images with consensus at our 
neuroradiology board. No patients underwent imme-
diate postoperative irradiation for residual disease.
Statistical analyses
The analysis was conducted using the R software 
program, version 3.5.1. Recurrence was analyzed 
using the Kaplan–Meier method. The log-rank test 
was used to assess the significance of recurrence 
rates. The Cox proportional hazard test was performed 
for multivariate analyses of recurrence. The nonpara-
metric Kruskal–Wallis model was used to compare 
independent significant factors of recurrence time. 
Post hoc tests of continuous variables were performed 
by the Steel–Dwass test. Fisher’s test was also used 
in the analysis of categorical parameters. Postoper-
ative KPS changes were evaluated using Wilcoxon 
signed rank test. Continuous variables, including 
the patient age, tumor size, time to recurrence and 
duration of follow-up, were expressed as the median 
Fig. 1 Schematic drawings of subgroups showing surgical cleavage (black arrows) in the brain–meningioma 
interface. (A) Extra-H group: Extra-arachnoid dissection cleavage is made between a meningioma with fibrotic 
change (gray) and a hypertrophic arachnoid membrane (thick blue line). (B) Extra-N group: Extra-arachnoid 
cleavage is made between a meningioma and an arachnoid membrane (thin blue line) without hypertrophic 
changes. C1 and C2, Subpial group: Subpial dissection for a meningioma with fibrotic change (gray) merged 
with a hypertrophic arachnoid membrane (thick blue line) and pia mater (thin orange line) (C1) and for 
another with a disrupted arachnoid membrane (thin blue line) and pia mater (thin orange line) without fibrotic 
changes (C2). 
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values with the interquartile range (IQR). A p value 
of <0.05 was considered significant.
Results
Patients’ characteristics and operative data
A total of 111 patients were enrolled (Supplementary 
Table 2). Eighty-one were women. The mean age at 
surgery was 59.8 ± 12.9 years old. Tumor sizes 
ranged from 10 to 104 mm (median 31 [25–44] mm). 
There were 70 skull base meningiomas (63%) and 
41 non-skull base meningiomas (36.9%). This high 
ratio of skull base lesions was due to the tendency 
of patients to be referred to us in our local district. 
Ninety-eight (88.3%) patients received Simpson 
Grade I to III resection and 13 (11.7%) Grade IV 
resection. The median duration of postoperative 
follow-up was 97.0 [70.0–124.0] months.
Dissection cleavages in the interface were extrapial 
for 95 patients (85.6%; Extra-H and Extra-N groups) 
and subpial for 16 patients (14.4%; Subpial group). 
Of the 95 meningiomas with extrapial dissection, 
56 had hypertrophic arachnoid membranes that 
were intently preserved in the interface (Extra-H 
group). Table 1 shows the differences in the clinical 
features of the subgroups. The patients in the Extra-H 
group were older, and those in the Subpial group 
had significantly larger meningiomas with a higher 
incidence of perifocal edema, pial feeders, and pial 
disruption than other groups. There were small pial 
defects less than one-quarter of the total interface 
observed in patients of the Extra-H (28%) and 
Extra-N (20.5%) groups. Immediate postoperative 
MR imaging demonstrated enhancement of 
hypertrophic arachnoid membrane in 66% of patients 
from Extra-H group. Figure 2 demonstrates preop-
erative and postoperative MR images with contrast 
media in representative patients of the Extra-H 
group.
Recurrence of meningiomas
Tumor recurrence or progression was radiologically 
detected in 13 (11.7%) patients: 1 at both the brain 
and dura mater, 12 only at the dura mater (Fig. 3A). 
Table 2 shows the results of uni- and multivariate 
analyses. The analysis of the 13 total recurrences 
did not show significant differences in the regrowth 
or the recurrence-free survival (RFS) among subgroups 
(log-rank P = 0.68, Fig. 3B). However, the difference 
reached statistical significance among Simpson 
grades (log-rank P <0.001, multivariate hazard ratio 
[HR]: 2.18; P = 0.016, Fig. 3C).
Tumors recurred at the brain surface in a single 
(0.9%) patient (Fig. 2B) associated with recurrence 
in the dura mater at the same time. Only a univar-
iate analysis was performed for factors in the 
recurrence in the brain, as the number of events 
was too small to run calculations to converge for 
a multivariate analysis. The differences in the RFS 
from the brain surface did not reach significance 
for the gender, age, tumor size, location, preoper-
ative KPS, Simpson grade, or interface subgroup 
(Table 2).
Morbidity and functional status by surgical 
treatments of the interface
There were no surgical mortalities. Two patients 
experienced postoperative transient neurological 
Table 1 Differences in patient features among the subgroups
Factors Extra-H Group N = 56 Figure 1A
Extra-N Group N = 39 
Figure 1B




Size (mm) mean/SD 37.7/16.6 28.4/11.8 42.6/15.8 P <0.001
Post hoc analysis H:N P = 0.009, N:Sub P = 0.004, Sub:H P = 0.45
Age (years) mean/SD 63.5/11.5 54.8/12.7 58.8/14.4 P = 0.01
Post hoc analysis H:N P = 0.006, N:Sub P = 0.55, Sub:H P = 0.55
Location SB:non-SB 35:21 29:10 6:10 P = 0.039
Perifocal edema Y:N 25:31 9:30 12:4 P = 0.0014
Pial feeders Y:N 12:44 5:34 6:10 P = 0.13
Pia disruption Y:N 16:40 8:31 14:2 P <0.001
Simpson Gr I-III:IV 52:4 31:8 15:1 P = 0.256
KPS mean/SD Preop
Postop










Preop: preoperative, Postop: postoperative, SB: skull base, SD: standard deviation, Y: N: Yes or No.
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deficits but had recovered to their preoperative 
condition by the 3-month follow-up visit after 
surgery. Another three in the Subpial group had 
permanent worsening of their function. These three 
patients accounted for 2.7% of all patients and 
18.8% of those in the Subpial group.
Preoperatively, 12 patients were moderately 
disabled with a KPS <70/100. The preoperative KPS 
was significantly lower in patients ≥60 than in those 
<60 years old (P = 0.001). The functional score by 
KPS was significantly improved in Extra-H and 
Extra-N groups, but not in the Subpial group at 3 
months after surgery (Fig. 3D).
A preoperative history of epilepsy was noted in 
six patients, two of whom had long histories of 
idiopathic epilepsy treated at an epilepsy center. 
Postoperatively, novel epileptic seizures developed 
in two patients, including one patient at 6 months 
after total and Extra-H resection for a parietal convexity 
meningioma and another at 12 months after subpial 
total removal (Subpial group) for a frontal convexity 
meningioma. At the latest follow-up visits, 14 patients, 
including these two patients, had received anticon-
vulsants and were all seizure-free. The rate of anti-
convulsant prescription showed no significant differ-
ence among the subgroups (P = 0.26).
Fig. 2 MR images showing preoperative meningioma and early postoperative enhancement at the brain surface. 
(A) Axial enhanced T1-weighted images demonstrating a preoperative tumor (left), redundant sheets of hypertro-
phic arachnoid membranes on the brain surface 17 hours after resection (middle), and disappearance of the 
abnormal enhancement 6 months after surgery (right) for a 60-mm meningioma by Simpson Grade II and Extra-H 
resection. The patient has been asymptomatic without recurrence 84 months after surgery. (B) Axial enhanced 
T1-weighted images demonstrating a preoperative tumor (left), sheets of hypertrophic arachnoid membranes on 
the brain surface 20 hours after resection (middle), and recurrent lesions at the brain surface (white arrow) and 
dura mater 60 months after initial surgery for a 30-mm meningioma by Simpson Grade II and Extra-H resection 
(right). MR: magnetic resonance. 
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Discussion
Abnormal arachnoid membrane at the interface of 
the brain and meningioma
The microscopic anatomy of the interface revealed 
that meningiomas induce fibrotic changes and 
abnormal arachnoid membranes of varying thickness 
and disruption with or without hypertrophic 
changes.15) These abnormal changes of arachnoid 
membranes seem mixed, redundant or partial in 
the interface. In this series of 111 consecutive 
patients, hypertrophic arachnoid membranes were 
found and preserved in the interface of 56 (50.5%) 
patients (Extra-H group), and hypertrophic and/or 
disrupted arachnoid membranes were removed in 
16 (14.4%) patients (Subpial group); therefore, 
abnormal arachnoid membranes were found in 
72 patients (64.9%) during microsurgery. Sindou 
Fig. 3 (A–C) Kaplan–Meier curves of the actuarial RFS probability according to the sites at the brain surface and 
dura mater (A), according to the interface subgroups (B), and according to the Simpson grades (C). (D) Plots of the 
means and standard deviations for the preoperative and 3-month postoperative KPSs. Patients from the Extra-H group 
and Extra-N group showed significant improvements in their postoperative scores, but patients from the Subpial group 
remained (*Wilcoxon signed rank test; P <0.01). KPS: Karnofsky Performance Scores, RFS: recurrence-free survival. 
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and Alaywan reported that the arachnoid cleavage 
plane was achieved in only 54.6% of 150 meningiomas.11) 
Subsequently, Alvernia et al. reported their expe-
rience in surgical cleavability restricted to convexity 
meningiomas of WHO Grade I.12) In those studies, 
subpial dissection was discussed without any 
information on abnormal arachnoid membranes at 
the interface. Kamitani et al. first reported micro-
scopic tumor cell clusters in thick arachnoid 
membranes surrounding meningioma and assumed 
their clinical importance in recurrence13) On the 
other hand, the incidence of arachnoid disruption 
(perforation) was reported in two studies to be 26% 
and 63.6%.17,18) The arachnoid and pial disruption 
found during surgical dissection may be induced 
by several mechanisms: by tumor protrusion on 
the brain surface together with a reduced consis-
tency of pia-arachnoid membranes or by true brain 
invasion. True brain invasion is a pathological 
diagnosis defined as tumor tissue within the adjacent 
brain without a separating connective tissue layer.19,20) 
Therefore, surgeons cannot differentiate true brain 
invasion from tumor protrusion into the cortex 
through the simple perforation of pia- arachnoid 
membranes when they take an approach empha-
sizing preservation of the arachnoid membranes on 
the brain.
Abnormal arachnoid membranes and recurrence
The precise recurrence sites, whether the dura 
mater or brain surface, have been rarely reported 
even in articles discussing the surgical cleavage or 
surgical treatment at the brain–tumor interface. 
Kamitani et al. reported that thick arachnoid 
membrane remnants were related to meningioma 
recurrence; however, the details concerning the recur-
rence sites were unclear.13) Yamasaki et al. reported 
meningioma recurrence in 6 of 54 patients after 
Simpson Grade I resection of convexity meningiomas, 
and they were all found in the brain.5) The authors 
presented no findings at the brain–tumor interface 
or dissection cleavage in their series. Several studies 
have reported that subpial cleavage and brain inva-
sion showed predictive value for recurrence after 
surgery in cases of intracranial meningiomas.11,12,19) 
However, the exact focuses of recurrence, possible 
remnants, and abnormal membranes on the brain 
surface were not clearly presented in these studies. 
The features of recurrence at the brain surface 
may be elucidated by three-dimensional MR imaging, 
which is now widely used for patients with 
meningioma.
The present study revealed only one recurrence 
in the brain among 56 patients in the Extra-H group 
after a median follow-up of 97 months (Table 2, 
Fig. 3C). The result suggests that remnant menin-
gioma cells in the preserved hypertrophic arachnoid 
membranes might become the focus of rare tumor 
recurrence after gross total removal of the tumor 
body. Extra-H group patients were significantly older 
than those in the Extra-N group or Subpial group 
(Table 1). Therefore, conservative dissection at the 
interface should be seriously considered, as stripping 
the abnormal membranes from the brain surface 
might cause neurological deterioration or sequelae, 
especially in older patients.
Table 2 Uni- and multivariate analyses of the RFS
Variable







Age (>60 years) P = 0.035 HR 2.79 P = 0.13 P = 0.32
Sex P = 0.85 P = 0.53
Size (>30 mm) P = 0.31 HR 0.77 P = 0.65 P = 0.26
Location (SB:NSB) P = 0.058 HR 2.37 P = 0.29 P = 0.40
KPS (>70/100) P = 0.47 P = 0.66
Brain edema P = 0.75 P = 0.24
Pial feeders P = 0.97 P = 0.075
Subgroup by interface P = 0.68 P = 0.55
Simpson grade P <0.001 HR 2.18 P = 0.016 P = 0.73
HR: hazard ratio, KPS: Karnofsky performance score, NSB: non-skull base, RFS: 
recurrence-free survival, SB: skull base.
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In addition, the present study showed the recur-
rence rate in the dura mater was 11.7% with a 
median follow-up of 97 months, which is within 
the range reported in the literature.16,21,22) And the 
study revealed that recurrence at the dura mater 
was not related to the interface subgroups (Table 2, 
Fig. 3B). These results suggest that the presence of 
hypertrophic arachnoid membrane alone does not 
reflect a high or low proliferation potential of 
meningioma recurrence in the dura.
Operative morbidity and treatments of abnormal 
arachnoid membranes
In our series, there were no surgical mortalities. 
The overall surgical morbidity rate was 4.5% (5 
in 111 patients), including transient palsy. Previous 
studies have reported that the rate of experiencing 
a new or worsened deficit ranged from 8.3% to 
14.8%.11,23) In this study, 4 of 5 patients who 
suffered neurological deterioration were in the 
Subpial group, which showed a morbidity rate 
of 25% (4/16). Furthermore, the postoperative 
KPS did not improve in the Subpial group while 
those significantly improved in the other groups 
(Table 1, Fig. 3D). All patients who had a dete-
riorated in KPS in the Subpial group were ≥60 
years old. These operative morbidity factors need 
to be assessed in addition to the tumor location 
and comorbidity that have been discussed in the 
literature.23)
The onset of seizures after meningioma surgery 
is a concern, especially after subpial resection. In 
the present study, new-onset seizures occurred in 
two patients (1.8%; one in the Extra-H group and 
another in the Subpial group). This result is in line 
with recent literature indicating new-onset seizure 
rates of 1.9%–19.4%.23,24) All 111 of the present 
patients were seizure-free at their last follow-up 
visit, and 12.6% were under control with anticon-
vulsants.
Study limitations
The observational nature of the study along with 
the subjective and qualitative assessments of the 
surgical findings without random assignment needs 
to be considered when evaluating the results. Thor-
ough sampling of the hypertrophic arachnoid 
membrane for pathological examination was not 
allowed to preserve the brain and critical structures. 
Immediate postoperative MR imaging did not always 
demonstrate enhancement of the preserved membranes, 
making volumetric assessment of the remnants 
impossible on the brain surface after surgery. Recur-
rence was not confirmed histologically in several 
cases, as the recurrent tumors were diagnosed at a 
small size in asymptomatic patients by routine 
follow-up imaging.
Intraoperative decision of dissection cleavage is 
difficult for surgeons especially over critical struc-
tures if an intraoperative frozen section suggested 
that the tumor had borderline aggressive features. 
During the study period, we removed nine WHO 
Grade II meningiomas with the same approach of 
preserving the arachnoid membranes in the interface. 
Two (22.2%) of nine WHO Grade II meningiomas 
recurred at the brain surface, whereas one (0.9%) 
of 111 WHO Grade I meningiomas (log-rank P <0.0001). 
Careful follow-up with MR imaging should be 
planned for patients who undergo membrane- 
preserving resection at the interface. We believe 
that the inclusion of more patients and extended 
follow-up would aid in validating our findings.
Conclusions
The surgical preservation of hypertrophic arachnoid 
membranes in the brain–tumor interface did not 
increase the risk of recurrence from the brain surface 
in WHO Grade I meningiomas. The postoperative 
KPS did not improve in patients who received 
subpial resection. Considering the postoperative 
quality of life in meningioma patients, the authors 
believe that aggressive attempts to remove abnormal 
arachnoid membranes in the interface are less bene-
ficial than simple resection for WHO Grade I menin-
giomas. However, careful follow-up with MR imaging 
should be planned for patients who undergo 
membrane-preserving resection at the interface.
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